Press coverage about Stericycle (NASDAQ:SRCL) has trended somewhat positive on Tuesday, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Stericycle earned a daily sentiment score of 0.15 on Accern’s scale. Accern also gave media stories about the business services provider an impact score of 46.7380216636169 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

These are some of the news articles that may have impacted Accern Sentiment Analysis’s scoring:

Shares of Stericycle (NASDAQ:SRCL) traded up $0.56 during trading on Tuesday, reaching $72.16. The company had a trading volume of 748,640 shares, compared to its average volume of 662,640. Stericycle has a twelve month low of $61.25 and a twelve month high of $88.00. The company has a market cap of $6,160.00, a price-to-earnings ratio of -128.86, a price-to-earnings-growth ratio of 1.74 and a beta of 0.16. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Wednesday, November 8th. The business services provider reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.04). Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The firm had revenue of $883.00 million during the quarter, compared to the consensus estimate of $896.81 million. During the same period in the previous year, the firm earned $1.24 earnings per share. The business’s quarterly revenue was down .8% on a year-over-year basis. sell-side analysts predict that Stericycle will post 4.49 earnings per share for the current fiscal year.

Several research firms have recently weighed in on SRCL. Oppenheimer reissued a “hold” rating on shares of Stericycle in a research report on Wednesday, December 13th. Royal Bank of Canada lowered their price objective on Stericycle from $74.00 to $67.00 and set an “underperform” rating for the company in a research report on Thursday, November 9th. Stifel Nicolaus reissued a “buy” rating and issued a $85.00 price objective on shares of Stericycle in a research report on Thursday, December 28th. Jefferies Group set a $108.00 price objective on Stericycle and gave the stock a “buy” rating in a research report on Tuesday, October 17th. Finally, Barrington Research lowered their price objective on Stericycle from $87.00 to $75.00 and set an “outperform” rating for the company in a research report on Friday, November 10th. Three analysts have rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $74.45.

In related news, Director Mark C. Miller sold 19,753 shares of the business’s stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $70.52, for a total value of $1,392,981.56. Following the completion of the sale, the director now directly owns 205,576 shares of the company’s stock, valued at approximately $14,497,219.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 79,012 shares of company stock valued at $5,240,668 over the last ninety days. 3.50% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “Stericycle (SRCL) Given Daily Coverage Optimism Score of 0.15” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at

About Stericycle

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Insider Buying and Selling by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with's FREE daily email newsletter.